Big Pharma Advances on COVID-19
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk and Zoom Video Communications.
Thursday's top analyst upgrades, downgrades and initiations included Applied Materials, Cisco Systems, Cognizant Technology Solutions, Costco Wholesale, Enphase Energy, Medtronic, Shopify, Starbucks, Teva Pharmaceutical and Xilinx.
24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid and dependable dividends. These five make sense for growth and income investors.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Chevron, Cimarex, DocuSign, General Electric, IBM, Micron Technology, Microsoft, Nvidia, Tesla and Western Digital.
Top analyst upgrades, downgrades and initiations for the first trading day of 2020 included Abbott Laboratories, Advanced Micro Devices, Analog Devices, Applied Materials, Ford, Illumina, Medtronic, Tesla and Wells Fargo.
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
The top analyst upgrades, downgrades and initiations on Thursday included Advanced Micro Devices, Apple, Chipotle Mexican Grill, Costco, Exxon Mobil, Netflix, Qualcomm, Ulta Beauty and U.S. Bancorp.
The top analyst upgrades, downgrades and initiations on Thursday included Abbott Laboratories, CenterPoint Energy, Dominion Energy, Delphi Technologies, Dollar General, Lennar, Lululemon Athletica, Visa, Walt Disney and Zillow.
Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value going forward.
Stifel analysts continue to favor staples, health care, utilities and telecom for 2019. These companies in those categories paid the highest dividends and their stocks look like solid picks for investors.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Apple, Apptio, Cheniere Energy, First Solar, Kratos Defense & Security Solutions, Smartsheet, UPS and Waste Management.
The top analyst upgrades, downgrades and initiations seen on Friday include Dollar Tree, Goldman Sachs, Palo Alto Networks, Sony and Under Armour.